ICD-10 Code C84.72 | Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes Symptoms, Diagnosis, Billing

Anaplastic large cell lymphoma (ALCL), ALK-negative, is a type of non-Hodgkin lymphoma characterized by the proliferation of large, anaplastic lymphoid cells. This subtype typically presents in the intrathoracic lymph nodes and is associated with aggressive clinical behavior. Accurate coding with ICD-10 Code C84.72 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code C84.72 for Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes?

ICD-10 Code C84.72 specifically denotes Anaplastic large cell lymphoma, ALK-negative, affecting the intrathoracic lymph nodes. This code is utilized in clinical documentation and billing when diagnosing patients with this aggressive lymphoma subtype, facilitating appropriate treatment plans and ensuring accurate reimbursement for healthcare services rendered.

ICD-10 Code C84.72 – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes

Anaplastic large cell lymphoma, ALK-negative, is a hematological malignancy that arises from T-cell lineage and is characterized by the presence of large, atypical lymphoid cells. The condition often presents with lymphadenopathy, particularly in the thoracic region, and requires prompt medical intervention due to its aggressive nature.

Key Clinical Features:

• Presence of large, atypical lymphoid cells on histopathological examination.
• Commonly presents with lymphadenopathy in the chest or mediastinum.
• May be associated with systemic symptoms such as fever, night sweats, and weight loss.
• Higher incidence in young adults and adolescents.

ICD-10 Code C84.72 for Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes – SOAP Notes & Clinical Use

ICD-10 Code C84.72 is integral to the SOAP note framework, aiding in the documentation of patient symptoms, assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and facilitating accurate billing processes.

What Does ICD-10 Code C84.72 for Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C84.72 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative. This code is crucial for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C84.72 – Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes

The management of Anaplastic large cell lymphoma, ALK-negative, often necessitates hospitalization due to its aggressive nature. Treatment typically involves chemotherapy and may require supportive care measures.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Management of symptoms such as pain and fever.
• Nutritional support to maintain strength during treatment.
• Psychosocial support for patients and families.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Monitoring for signs of infection during chemotherapy.

How to Document Symptoms of Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes (ICD-10 C84.72) in SOAP Notes

Subjective:

• Patient reports persistent fatigue and unexplained weight loss.
• Complaints of night sweats and fever over the past month.
• Notable swelling in the neck and chest area.

Objective:

• Physical examination reveals enlarged lymph nodes in the cervical and supraclavicular regions.
• Chest imaging shows mediastinal lymphadenopathy.
• Laboratory tests indicate elevated lactate dehydrogenase (LDH) levels.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes (ICD-10 Code C84.72)

Assessment:

• Diagnosis: Anaplastic large cell lymphoma, ALK-negative, affecting intrathoracic nodes.
• Severity: Aggressive with potential for systemic involvement.
• Contributing factors: Possible prior viral infections or genetic predispositions.

Plan:

• Initiate chemotherapy regimen as per oncology guidelines.
• Provide education on potential side effects and symptom management.
• Schedule follow-up appointments for monitoring treatment response.

Treatment & Plan Section for ICD-10 Code C84.72 – Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes

• First-line treatment typically includes multi-agent chemotherapy.
• Consideration of targeted therapies based on patient-specific factors.
• Regular monitoring of blood counts and imaging studies to assess treatment efficacy.
• Patient education on lifestyle modifications and support resources.

Using ICD-10 Code C84.72 for Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in the Subjective and Objective sections.
• Utilize C84.72 in conjunction with appropriate treatment codes for comprehensive billing.
• Align treatment plans with clinical guidelines to support justified billing.
• Regularly review coding updates to maintain compliance with payer requirements.

Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes

• C84.71 – Anaplastic large cell lymphoma, ALK-positive, intrathorac nodes

ICD-10 Code C84.72 in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes

ICD-10 Code C84.72 is critical in medical billing, particularly in hospital and emergency settings, ensuring accurate representation of the patient's diagnosis.

Billing Notes:

• Document all relevant clinical findings to support the use of C84.72.
• Use this code in inpatient and outpatient settings for consistency.
• Ensure that treatment plans are clearly outlined in the medical record to justify billing.

Common CPT Pairings: